Notably, research on cognitively healthy individuals at elevated AD risk, such as apolipoprotein E (APOE) ε4 carriers and those with familial AD history, shows increased CT and larger choroidal vascular indices. The gene discussed is APOE; the disease is Alzheimer disease.